Cluster RCT | A personalized cooler dialysate provides no benefit for patients receiving maintenance hemodialysis.

Personalised cooler dialysate for patients receiving maintenance haemodialysis (MyTEMP): a pragmatic, cluster-randomised trial – The Lancet (link to abstract – $ for full-text) 

Commentary: Clinical trial examines optimal dialysis temperature – University of Western Ontario 

Commentary on Twitter (thread – click for more) 

Over 2 million people worldwide with #kidneyfailure rely on maintenance #dialysis treatments.

Trial, MyTEMP, assesses the effects of cooler dialysate compared with standard temperature in individuals receiving outpatient maintenance dialysis.? pic.twitter.com/M9JscDqM2v

— The Lancet (@TheLancet) November 17, 2022